APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotherapy-induced Nausea and Vomiting Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chemotherapy-induced Nausea and Vomiting Drugs Industry Growth and Trends Forecast to 2032

22 December 2025108 pages

Choose your research edition.

Industry ResearchChemotherapy-induced Nausea and Vomiting Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotherapy-induced Nausea and Vomiting Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Chemotherapy-induced Nausea and Vomiting Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chemotherapy-induced Nausea and Vomiting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chemotherapy-induced Nausea and Vomiting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemotherapy-induced Nausea and Vomiting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chemotherapy-induced Nausea and Vomiting Drugs include Eisai, Teva, Novartis, Merck, Mylan, Roche, Tesaro, Qilu Pharma and Mundipharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chemotherapy-induced Nausea and Vomiting Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chemotherapy-induced Nausea and Vomiting Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chemotherapy-induced Nausea and Vomiting Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chemotherapy-induced Nausea and Vomiting Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chemotherapy-induced Nausea and Vomiting Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chemotherapy-induced Nausea and Vomiting Drugs Market by Company

Eisai

Teva

Novartis

Merck

Mylan

Roche

Tesaro

Qilu Pharma

Mundipharma

Heron Therapeutics

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Type

5-HT3 Inhibitors

NK1 Inhibitors

Other

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Application

Moderately Emetogenic Chemotherapy

Highly Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Other

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy-induced Nausea and Vomiting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy-induced Nausea and Vomiting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy-induced Nausea and Vomiting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chemotherapy-induced Nausea and Vomiting Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chemotherapy-induced Nausea and Vomiting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5-HT3 Inhibitors Table 2. Major Company of NK1 Inhibitors Table 3. Major Company of Other Table 4. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 6. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2026) & (US$/unit) Table 10. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 11. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2027-2032) & (US$/unit) Table 15. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 16. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 18. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 22. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Chemotherapy-induced Nausea and Vomiting Drugs Industry Trends Table 26. Chemotherapy-induced Nausea and Vomiting Drugs Industry Drivers Table 27. Chemotherapy-induced Nausea and Vomiting Drugs Industry Opportunities and Challenges Table 28. Chemotherapy-induced Nausea and Vomiting Drugs Industry Restraints Table 29. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Company (2021-2026) & (k units) Table 32. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Company (2021-2026) Table 33. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Chemotherapy-induced Nausea and Vomiting Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Chemotherapy-induced Nausea and Vomiting Drugs Major Company Production Sites and Headquarters Table 36. Global Chemotherapy-induced Nausea and Vomiting Drugs Company, Product Type & Application Table 37. Global Chemotherapy-induced Nausea and Vomiting Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Chemotherapy-induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2021-2026) & (k units) Table 42. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 58. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2027-2032) & (US$/unit) Table 62. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 63. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 65. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 69. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Eisai Company Information Table 73. Eisai Business Overview Table 74. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 76. Eisai Recent Development Table 77. Teva Company Information Table 78. Teva Business Overview Table 79. Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Teva Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 81. Teva Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 86. Novartis Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Merck Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 91. Merck Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 96. Mylan Recent Development Table 97. Roche Company Information Table 98. Roche Business Overview Table 99. Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Roche Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 101. Roche Recent Development Table 102. Tesaro Company Information Table 103. Tesaro Business Overview Table 104. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 106. Tesaro Recent Development Table 107. Qilu Pharma Company Information Table 108. Qilu Pharma Business Overview Table 109. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 111. Qilu Pharma Recent Development Table 112. Mundipharma Company Information Table 113. Mundipharma Business Overview Table 114. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 116. Mundipharma Recent Development Table 117. Heron Therapeutics Company Information Table 118. Heron Therapeutics Business Overview Table 119. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 121. Heron Therapeutics Recent Development Table 122. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 124. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2021-2026) Table 125. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032) & (k units) Table 126. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country (2021-2026) Table 130. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Country (2027-2032) Table 132. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 134. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2021-2026) Table 135. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032) & (k units) Table 136. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country (2021-2026) Table 140. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 144. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032) & (k units) Table 146. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country (2021-2026) Table 150. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Country (2027-2032) Table 152. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 154. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2021-2026) Table 155. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032) & (k units) Table 156. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country (2021-2026) Table 160. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032) & (k units) Table 166. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country (2021-2026) Table 170. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Chemotherapy-induced Nausea and Vomiting Drugs Distributors List Table 175. Chemotherapy-induced Nausea and Vomiting Drugs Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Chemotherapy-induced Nausea and Vomiting Drugs Image Figure 2. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (2021-2032) & (k units) Figure 5. 5-HT3 Inhibitors Image Figure 6. Global 5-HT3 Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. NK1 Inhibitors Image Figure 8. Global NK1 Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Chemotherapy-induced Nausea and Vomiting Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Moderately Emetogenic Chemotherapy Image Figure 26. Global Moderately Emetogenic Chemotherapy Sales YoY Growth (2021-2032) & (k units) Figure 27. Highly Emetogenic Chemotherapy Image Figure 28. Global Highly Emetogenic Chemotherapy Sales YoY Growth (2021-2032) & (k units) Figure 29. Low Emetogenic Chemotherapy Image Figure 30. Global Low Emetogenic Chemotherapy Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Chemotherapy-induced Nausea and Vomiting Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Chemotherapy-induced Nausea and Vomiting Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Other
Applications
  • Moderately Emetogenic Chemotherapy
  • Highly Emetogenic Chemotherapy
  • Low Emetogenic Chemotherapy
  • Other
Companies covered
  • Eisai
  • Teva
  • Novartis
  • Merck
  • Mylan
  • Roche
  • Tesaro
  • Qilu Pharma
  • Mundipharma
  • Heron Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chemotherapy-induced Nausea and Vomiting Drugs Market by Type
  6. 1.3.1 5-HT3 Inhibitors
  7. 1.3.2 NK1 Inhibitors
  8. 1.3.3 Other
  9. 1.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  10. 1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chemotherapy-induced Nausea and Vomiting Drugs Industry Trends
  2. 2.2 Chemotherapy-induced Nausea and Vomiting Drugs Industry Drivers
  3. 2.3 Chemotherapy-induced Nausea and Vomiting Drugs Industry Opportunities and Challenges
  4. 2.4 Chemotherapy-induced Nausea and Vomiting Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Chemotherapy-induced Nausea and Vomiting Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Chemotherapy-induced Nausea and Vomiting Drugs Price (2021-2026)
  4. 3.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Chemotherapy-induced Nausea and Vomiting Drugs Company, Product Type & Application
  7. 3.7 Global Chemotherapy-induced Nausea and Vomiting Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chemotherapy-induced Nausea and Vomiting Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chemotherapy-induced Nausea and Vomiting Drugs Tier 1, Tier 2, and Tier 3
4 Chemotherapy-induced Nausea and Vomiting Drugs Regional Status and Outlook
  1. 4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Historic Market Size by Region
  3. 4.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chemotherapy-induced Nausea and Vomiting Drugs by Application
  1. 5.1 Chemotherapy-induced Nausea and Vomiting Drugs Market by Application
  2. 5.1.1 Moderately Emetogenic Chemotherapy
  3. 5.1.2 Highly Emetogenic Chemotherapy
  4. 5.1.3 Low Emetogenic Chemotherapy
  5. 5.1.4 Other
  6. 5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  7. 5.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Tesaro
  38. 6.7.1 Tesaro Company Information
  39. 6.7.2 Tesaro Business Overview
  40. 6.7.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  42. 6.7.5 Tesaro Recent Developments
  43. 6.8 Qilu Pharma
  44. 6.8.1 Qilu Pharma Company Information
  45. 6.8.2 Qilu Pharma Business Overview
  46. 6.8.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  48. 6.8.5 Qilu Pharma Recent Developments
  49. 6.9 Mundipharma
  50. 6.9.1 Mundipharma Company Information
  51. 6.9.2 Mundipharma Business Overview
  52. 6.9.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  54. 6.9.5 Mundipharma Recent Developments
  55. 6.10 Heron Therapeutics
  56. 6.10.1 Heron Therapeutics Company Information
  57. 6.10.2 Heron Therapeutics Business Overview
  58. 6.10.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  60. 6.10.5 Heron Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
  2. 7.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  6. 7.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
  2. 8.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  6. 8.2.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
  2. 10.1.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  6. 10.2.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chemotherapy-induced Nausea and Vomiting Drugs Value Chain Analysis
  2. 12.1.1 Chemotherapy-induced Nausea and Vomiting Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chemotherapy-induced Nausea and Vomiting Drugs Production Mode & Process
  7. 12.2 Chemotherapy-induced Nausea and Vomiting Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Distributors
  10. 12.2.3 Chemotherapy-induced Nausea and Vomiting Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst